Orgenesis announced that it has entered into a collaboration agreement with Digilab to develop a live cell printing process and systems designed to automate the production of three-dimensional live cellular structures and tissues. Under the agreement, Orgenesis will have the exclusive rights to co-develop the process and systems required for its therapeutic collaboration programs and to utilize, market and distribute the new cell printer systems and related products.
https://thefly.com/landingPageNews.php?id=2888669
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.